Last month, the Kentucky legislature overrode Governor Matt
Bevin’s veto and passed HB366 (here),
a tax reform bill that increased cigarette excise taxes from $0.60 to $1.10, while
leaving taxes on smokeless products unchanged and leaving e-cigarettes with no
excise tax.
This policy mirrors the tax plan that my research group
designed (here)
– one endorsed by 16 tobacco research and economic policy experts from across
the nation, and by the Pegasus Institute (here). Watch my interview with Nick Storm of
Spectrum News here to learn more.
Enacting this plan, legislators rejected demands from anti-tobacco
crusaders to double the cigarette tax increase and make vastly safer smokeless
and e-cigarettes equally expensive. One
of their spokesmen, Foundation for a Healthy Kentucky president Ben Chandler, had
argued, “you’ve got to have the sticker shock…” (here)
That reasoning is both insensitive and nonsensical. Many Kentucky smokers are unable or unwilling
to quit tobacco and nicotine entirely.
For them, traditional quit-smoking methods, which strive for nicotine
and tobacco abstinence, don’t work.
Our tax plan encourages and incentivizes smokers to quit or
switch to less expensive and vastly safer smoke-free tobacco products, including
smokeless tobacco and e-cigarettes.
Decades of epidemiologic studies document that the health
risks of dipping and chewing tobacco are, at most, a mere two percent of those associated
with smoking. Unlike cigarettes, smokeless tobacco does not cause lung
cancer, heart and circulatory diseases or emphysema. A recent study
conducted by federal researchers and experienced epidemiologists found that men
who dip or chew tobacco have no excess risk for mouth cancer (here).
Our plan also encourages smokers to switch to e-cigarettes,
which already are among the most common – and most successful – quit aids in
the U.S. (here).
HB366 contains another provision favoring reduced risk
products. Kentucky excise taxes will be
reduced by half for products that are permitted by the FDA to be marketed as
“lower risk.”
Reduced risk applications have already been filed with the
FDA for three products: IQOS heat sticks, Camel Snus and Copenhagen moist
snuff. Science tells us that all of
these are vastly safer than cigarettes.
The question is: When will the FDA acknowledge this indisputable fact?
